Search Results - "Brigliadori, G"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Tyrosine kinase inhibitors gefitinib, lapatinib and sorafenib induce rapid functional alterations in breast cancer cells by Carloni, Silvia, Fabbri, Francesco, Brigliadori, Giovanni, Ulivi, Paola, Silvestrini, Rosella, Amadori, Dino, Zoli, Wainer

    Published in Current cancer drug targets (01-06-2010)
    “…Alterations in tyrosine kinase expression or functionality have been linked to tumor growth, and detailed analysis of tyrosine kinase pathways has led to the…”
    Get more information
    Journal Article
  2. 2

    Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells by Fabbri, F, Brigliadori, G, Ulivi, P, Tesei, A, Vannini, I, Rosetti, M, Bravaccini, S, Amadori, D, Bolla, M, Zoli, W

    Published in Apoptosis (London) (01-10-2005)
    “…Nitric oxide-releasing non steroidal anti-inflammatory drugs (NO-NSAIDs) are a promising class of compounds that cause cell cycle perturbations and induce…”
    Get full text
    Journal Article
  3. 3

    Modulation of drug cytotoxicity by iressa (ZD1839) in pancreatic cancer cell lines by Rosetti, M., Tesei, A., Ulivi, P., Fabbri, F., Vannini, I., Brigliadori, G., Granato, A.M., Amadori, D., Zoli, W.

    Published in Cancer biology & therapy (01-10-2005)
    “…High expression of the epidermal growth factor receptor (EGFR) family confers a growth advantage on malignant cells in various tumor types. Most pancreatic…”
    Get full text
    Journal Article
  4. 4

    Role of p53 codon 72 arginine allele in cell survival in vitro and in the clinical outcome of patients with advanced breast cancer by Vannini, I, Zoli, W, Tesei, A, Rosetti, M, Sansone, P, Storci, G, Passardi, A, Massa, I, Ricci, M, Gusolfino, D, Fabbri, F, Ulivi, P, Brigliadori, G, Amadori, D, Bonafe, M

    Published in Tumor biology (01-01-2008)
    “…The p53 codon 72 polymorphism, which results in either an arginine or proline residue, plays a different role in vitro and in vivo in cell survival and drug…”
    Get more information
    Journal Article
  5. 5

    Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines by Zoli, Wainer, Ulivi, Paola, Tesei, Anna, Fabbri, Francesco, Rosetti, Marco, Maltoni, Roberta, Giunchi, Donata Casadei, Ricotti, Luca, Brigliadori, Giovanni, Vannini, Ivan, Amadori, Dino

    Published in Breast cancer research : BCR (01-01-2005)
    “…The aim of the study was to evaluate the activity of a combination of doxorubicin (Dox), paclitaxel (Pacl) and 5-fluorouracil (5-FU), to define the most…”
    Get full text
    Journal Article
  6. 6

    Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: a cytometric study by Fabbri, Francesco, Carloni, Silvia, Brigliadori, Giovanni, Zoli, Wainer, Lapalombella, Rosa, Marini, Marina

    Published in BMC cell biology (26-01-2006)
    “…Despite the great advances in the understanding of programmed cell death, little attention has been paid to the sequence of the events that characterise it. In…”
    Get full text
    Journal Article